Patients with breast cancer with and without DM showed significant differences in terms of TNM stage, metastasized staging (M), tumor size staging (T), regional lymph node staging (N), HER2, tumor size, microcalcification, Adler blood flow grading, and prediction of lymph node metastasis. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.